Seres Therapeutics
(NASDAQ:MCRB)
$0.6358
0.0179[2.90%]
Last update: 9:14AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Seres Therapeutics Stock (NASDAQ:MCRB), Quotes and News Summary

Seres Therapeutics Stock (NASDAQ: MCRB) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.50.722K / 3.986M
Day Range- - -
52 Wk Range0.611 - 6.870
Market Cap$96.012M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
26
Short Interest
17.44%
Days to Cover6.22

Recent News

Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Why Is Microbiome-Based Seres Therapeutics Stock Trading Higher Today?
Seres Therapeutics Inc (NASDAQ: MCRB) received FDA Fast Track Designation for SER-155, an investigational oral, cultivated microbiome therapeutic designed to prevent GI-associated bacterial infections and to reduce the incidence of severe acute graft-versus-host disease in immunocompromised patients un
Vandana Singh
Dow Tumbles Over 200 Points; US Trade Gap Narrows In November
U.S. stocks traded lower this morning, with the Dow Jones falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.63% to 37,445.51 while the NASDAQ fell 0.66% to 14,745.96. The S&P 500 also fell, dropping, 0.55% to 4,737.17.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Jan
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Seres Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States....
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MCRB
ANIX

FAQ

Q

How do I buy Seres Therapeutics (MCRB) stock?

A

You can purchase shares of Seres Therapeutics (NASDAQ: MCRB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Seres Therapeutics's (MCRB) competitors?

A

Other companies in Seres Therapeutics’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Connect Biopharma Hldgs (NASDAQ:CNTB) and Burning Rock Biotech (NASDAQ:BNR).

Q

What is the target price for Seres Therapeutics (MCRB) stock?

A

The latest price target for Seres Therapeutics (NASDAQ: MCRB) was reported by Oppenheimer on Wednesday, March 6, 2024. The analyst firm set a price target for 5.00 expecting MCRB to rise to within 12 months (a possible 686.41% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Seres Therapeutics (MCRB)?

A

The stock price for Seres Therapeutics (NASDAQ: MCRB) is $0.6358 last updated Today at April 16, 2024 at 9:14 AM EDT.

Q

Does Seres Therapeutics (MCRB) pay a dividend?

A

There are no upcoming dividends for Seres Therapeutics.

Q

When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?

A

Seres Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Seres Therapeutics (MCRB) going to split?

A

There is no upcoming split for Seres Therapeutics.

Q

What sector and industry does Seres Therapeutics (MCRB) operate in?

A

Seres Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch